Development and validation of an early warning model for hospitalized COVID-19 patients: a multi-center retrospective

Jim M Smit1,2, Jesse H Krijthe3, Andrei N Tintu4

  • 1Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands. j.smit@erasmusmc.nl.

Insights

A new early warning model for COVID-19 patients demonstrated superior performance compared to general scores. This specialized model aids in timely identification of deteriorating patients, improving clinical management and ICU admission decisions.

Area of Science:

  • Medical Informatics
  • Clinical Prediction Models
  • Epidemiology

Background:

  • Timely identification of deteriorating COVID-19 patients is crucial for effective clinical management and intensive care unit (ICU) admission.
  • Existing Early Warning Scores (EWSs) may underestimate illness severity in COVID-19 patients.
  • Development of a specific early warning model for COVID-19 patients is warranted.

Purpose of the Study:

  • To develop and validate a novel early warning model tailored for COVID-19 patients.
  • To compare the performance of the new model against established EWSs.
  • To investigate methods for dynamic model updating to maintain performance over time.

Main Methods:

  • Retrospective collection of electronic medical record data from 3514 COVID-19 admissions across six Dutch hospitals.
  • Development of a random forest model using 18 predictors.
  • Temporal validation simulating real-world implementation during different COVID-19 waves, employing dynamic updating strategies.

Main Results:

  • The COVID-19 specific model achieved a higher discriminative performance (partial AUC 0.82) than the National early warning score (0.72) and Modified early warning score (0.67).
  • The model demonstrated greater net benefit across clinically relevant thresholds and good calibration.
  • SHapley Additive exPlanations values were used to quantify predictor importance.

Conclusions:

  • Specialized early warning models for specific patient groups, like COVID-19, offer potential benefits over general inpatient models.
  • The developed model shows promise for improving patient monitoring and care.
  • Further independent validation is recommended to confirm the model's generalizability and clinical utility.
Abstract